A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia
Condition: Leukemia Intervention: Other: No Intervention Sponsor: Takeda Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Gleevec | Leukemia | Nilotinib | Research | Study | Tasigna